1. Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen

   • Masayuki Inubushi
   • Hiroyuki Miura
   • Ryogo Minamimoto

   Invited Review Article Open access 11 November 2020 Pages: 879 - 883

2. The quantification of PET–CT radiotracers to determine minimal scan time using quadratic formulation

   • Mohamad Aminudin Said
   • Marianie Musarudin
   • Nur Farahiyah Zulkaffli

   Original Article 03 November 2020 Pages: 884 - 891

   

3. Causes of false negatives in technetium-99 m methoxyisobutylisonitrile scintigraphy for hyperparathyroidism: influence of size and cysts in parathyroid lesions

   • Shiro Ishii
   • Shigeyasu Sugawara
   • Hiroshi Ito

   Original Article 12 September 2020 Pages: 892 - 898

   

4. Reactor produced [⁶⁴Cu]CuCl₂ as a PET radiopharmaceutical for cancer imaging: from radiochemistry laboratory to nuclear medicine clinic

   • Rubel Chakravarty
   • Priyalata Shetty
   • Sudipta Chakraborty

   Original Article 13 October 2020 Pages: 899 - 910

   

5. Value of ¹⁸F-FDG PET/CT for prognostic stratification in patients with primary intestinal diffuse large B cell lymphoma treated with an R-CHOP-like regimen

   • Chong Jiang
   • Yue Teng
   • Jingyan Xu

   Original Article 15 October 2020 Pages: 911 - 919

   

6. Relapse-free survival after adjuvant radioactive iodine therapy in patients with differentiated thyroid carcinoma with a microscopically positive tumor margin

   • Ken Watanabe
   • Takao Igarashi
   • Hiroya Ojiri

   Original Article 17 September 2020 Pages: 920 - 925

   

7. The utility of a deep learning-based algorithm for bone scintigraphy in patient with prostate cancer

   • Yuki Aoki
   • Michihiro Nakayama
   • Atsutaka Okizaki

   Original Article 21 September 2020 Pages: 926 - 931

   

8. Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT

   • Meltem Caglar
   • Murat Tuncel
   • Erdem Karabulut

   Original Article 25 September 2020 Pages: 932 - 941

   

9. Metabolic changes in breast cancer on dual-time-point ¹⁸F-FDG PET/CT imaging according to primary tumor uptake and background parenchymal enhancement

   • Hye Ok Kim
   • Bom Sahn Kim
   • Hai-Jeon Yoon

   Original Article 24 September 2020 Pages: 942 - 951

   

10. Comparison of diagnostic accuracy between [¹⁸F]FDG PET/MRI and contrast-enhanced MRI in T staging for oral tongue cancer

    • Masafumi Kanno
    • Tetsuya Tsujikawa
    • Shigeharu Fujieda

    Original Article 10 October 2020 Pages: 952 - 959

    

11. Value of volumetric and textural analysis in predicting the treatment response in patients with locally advanced rectal cancer

    • Nazlı Pınar Karahan Şen
    • Ayşegül Aksu
    • Gamze Çapa Kaya

    Original Article 19 September 2020 Pages: 960 - 967

    

12. FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer

    • Romain-David Seban
    • Jean-Baptiste Assie
    • Laurence Champion

    Short Communication 18 October 2020 Pages: 968 - 974